Phase Ib / II Study of BAY 1000394 in Combination With Cisplatin / Etoposide or Carboplatin / Etoposide as First-line Therapy in Subjects With Extensive Disease Small Cell Lung Cancer
Phase of Trial: Phase I/II
Latest Information Update: 26 Apr 2017
At a glance
- Drugs Roniciclib (Primary) ; Carboplatin; Cisplatin; Etoposide
- Indications Small cell lung cancer
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- Sponsors Bayer
- 01 Jul 2016 The trial was completed in France (end date: 2016-03-08).
- 27 Jun 2016 Status changed from active, no longer recruiting to discontinued.
- 09 May 2016 Planned End Date changed from 1 Apr 2016 to 1 Jun 2016.